China
Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach...
September 26, 2024 | News
Huawei teamed up with partners to launch the Medical Technology Digitalization 2.0 Solution at the healthcare session named Enhancing Inclusivity to A...
September 24, 2024 | News
Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for ...
September 24, 2024 | News
Kangpu Biopharmaceuticals, a clinical-stage company based in Hefei, China, announced that the Company has successfully completed a bridging clinical s...
September 23, 2024 | News
CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application...
September 23, 2024 | News
Shanghai Henlius Biotech, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued ...
September 23, 2024 | News
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...
September 17, 2024 | News
ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk B...
September 16, 2024 | News
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...
September 11, 2024 | News
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced promising clinical data from an Inve...
September 11, 2024 | News
Nuance Pharma announced it has completed the recruitment of patients for the ENHANCE-CHINA (NCT05743075) study, after planned number of patients have ...
September 11, 2024 | News
GenAssist Ltd (GenAssist), announced the first DMD patient dosed with its base editing drug, GEN6050X injection, in an investigator-initiated trial (IIT). ...
September 10, 2024 | News
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners portfolio company, today announced it has received regulatory ap...
September 05, 2024 | News
Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, announced ...
September 04, 2024 | News
Most Read
Bio Jobs
News